ResMed RMD Global revenue — Net revenue by segment
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ResMed in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about ResMed's global revenue — net revenue by segment.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ResMed's global revenue — net revenue by segment?
- ResMed (RMD) reported global revenue — net revenue by segment of $1.43B in Q1 2026.
- How has ResMed's global revenue — net revenue by segment changed year-over-year?
- ResMed's global revenue — net revenue by segment increased by 10.8% year-over-year, from $1.29B to $1.43B.
- What is the long-term trend for ResMed's global revenue — net revenue by segment?
- Over 2 years (2022 to 2024), ResMed's global revenue — net revenue by segment has grown at a 14.4% compound annual growth rate (CAGR), from $3.58B to $4.69B.
- What does global revenue — net revenue by segment mean?
- This metric represents the total net sales generated by the company's global operations after accounting for returns, allowances, and discounts. It serves as the primary indicator of the company's market reach and the aggregate demand for its respiratory care products across all international territories. Tracking this figure allows investors to assess the company's ability to scale its core business and capture market share in the global sleep apnea and respiratory care landscape.